Natco Pharma Ltd's consolidated net profit more than doubled at ₹54 crore in the fourth quarter ended March 15, 2015, against ₹24 crore in the year-ago period. This was driven by a reversal of ₹31 crore of differed tax liabilities, the ... Hindu Business Line, 1 hour ago
Natco Pharma standalone net profit rises 147.15% in the March 2015 quarter - Business Standard, 3 hours ago
Natco Pharma gets board nod to raise up to $71M - VC Circle, 4 hours ago
Strides Arcolab's wholly owned subsidiaries viz., Strides Pharma Global Pte. Ltd, Singapore and Strides (Australia) Pharma Pty Ltd, Australia, have signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacare Holdings Ltd, ...PharmaBiz, 1 day ago Strides' arms to acquire pharma assets of Aspen Pharmacare in Australia Smart Investor, 1 day ago STRIDES ARCOLAB : to Acquire Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 4 Traders, 8 hours ago Strides Arcolab surges on acquisition plan of Aspen's generic pharma business in Australia Smart Investor, 1 day ago
Fosun Pharma, And WuXi PharmaTech Co., Ltd. To Jointly Acquire U.S. Innovative Biotechnology Company Ambrx, Inc.
SHANGHAI , May 2 1 , 2015 /PRNewswire/ -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi ...BioSpace, 4 hours ago Fosun Pharma (600196.SH; 02196.HK) to jointly acquire U.S. biotechnology firm Ambrx PredictWallStreet, 6 hours ago SHANGHAI FOSUN PHARMACEUTICAL : Fosun Pharma to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx 4 Traders, 7 hours ago Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx Wall Street Select, 18 hours ago
announced that the Board of Directors of the Company at its meeting held on 22 May 2015, inter alia, ha approved and taken on record the following:1. Increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / ...Business Standard, 5 hours ago Natco Pharma to hold EGM Capital Market, 5 hours ago Marksans Pharma Ltd Board to consider Dividend for 2014-15 Equity Bulls, 1 day ago Natco Pharma board meeting on May 22, 2015 Money Control, 4 days ago
Leerink Swann initiated coverage on Horizon Pharma PLC (NASDAQ: HZNP) with a Outperform rating. The target price for Horizon Pharma is set to $37. Horizon Pharma shares have gained 126.97 percent over the past 52 weeks, while the S&P 500 index has ...Benzinga.com, 5 hours ago J&J, big pharma's biotech threat Wall Street Business Network, 1 day ago
More from: NewsR.in, Marketplace...and 4 other sources
SBI is up 3 percent while Sun Pharma, HDFC, TCS and ONGC are top gainers in the Sensex. Among the losers are Bajaj Auto, Wipro, Vedanta, Hindalco and Hero Motocorp.Money Control, 9 hours ago Sensex, Nifty rangebound; Sun Pharma up, midcaps drag Money Control, 1 day ago Stocks in news: Wipro, ONGC, Syndicate Bank, RIL, Gammon Money Control, 2 days ago Sensex gains 363pts, Nifty ends above 8350; DRL, HDFC surge Money Control, 4 days ago
NEW DELHI: The S&P BSE Sensex surged 148 points on Friday, supported by gains in HDFC, TCS, Sun Pharma and L&T, but failed to close above its crucial psychological level of 28000. But the 50-share Nifty index managed to close above its crucial level of 8450, ...Economic Times, 6 hours ago Sensex may take another 4-5% cut: Here's why Economic Times, 2 weeks ago Sensex slips over 100 points, Nifty below 8050; Rupee hits 2015 low, ten stocks in focus Economic Times, 2 weeks ago Sensex down over 100 points, rupee hits 63.78 vs $ Economic Times, 2 weeks ago
Aditya Agarwal of Way2wealth Securities recommends going long in Sun Pharmaceutical Industries and Larsen Toubro.Money Control, 9 hours ago
In a chat with ET Now, Mitesh Thacker of miteshthacker.com, shares his view on Shasun Pharma Ltd. ET Now: What is your view on Shasun Pharma Ltd? Mitesh Thacker: Shasun Pharma Ltd is a 'BUY' with a target of Rs 386 and a stop loss ofEconomic Times, 10 hours ago
Rajat Bose of rajatkbose.com recommends buying ACC and advises looking at Sun Pharmaceutical Industries and Coal India.Money Control, 13 hours ago
on your WebpageAdd Widget >Get your members hooked!